CUMYL-NBMINACA
Chemical compound From Wikipedia, the free encyclopedia
CUMYL-NBMINACA (SGT-152, Cumyl-BC[2.2.1]HpMINACA) is a synthetic cannabinoid compound first reported in a 2013 patent,[1] but not identified as a designer drug until 2021, being identified by a forensic laboratory in Germany in February 2021.[2][3]
![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C25H29N3O |
Molar mass | 387.527 g·mol−1 |
3D model (JSmol) | |
| |
|
See also
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.